Grutters JC, van den Borsch JMM. Connective Tissue Disorders. Clinical Respiratory Medicine. Third ed2008. p. 713–27.
Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005;17(6):701–6.
Steen VD. The lung in systemic sclerosis. J Clin Rheumatol. 2005;11(1):40–6.
Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372–8.
Olson AL, Brown KK, Fischer A. Connective tissue disease-associated lung disease. Immunol Allergy Clin North Am. 2012;32(4):513–36.
Karimi-Shah BA, Chowdhury BA. Forced vital capacity in idiopathic pulmonary fibrosis–FDA review of pirfenidone and nintedanib. N Engl J Med. 2015;372(13):1189–91.
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18–47.
Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med. 2016;194(3):265–75.
Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37(2):356–63.
Suzuki A, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, et al. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: a retrospective cohort study. Clin Respir J. 2018;12(3):895–903.
Russell AM, Adamali H, Molyneaux PL, Lukey PT, Marshall RP, Renzoni EA, et al. Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2016;194(8):989–97.
Khan F, Howard L, Hearson G, Edwards C, Barber C, Jones S, et al. Clinical utility of home versus hospital spirometry in fibrotic interstitial lung disease: evaluation after INJUSTIS interim analysis. Ann Am Thorac Soc. 2022;19(3):506–9.
Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts J, Chavannes NH, et al. Home monitoring in patients with idiopathic pulmonary fibrosis. A randomized controlled trial. Am J Respir Crit Care Med. 2020;202(3):393–401.
Khor YH, Gutman L, Abu Hussein N, Johannson KA, Glaspole IN, Guler SA, et al. Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease: An International Cohort Study. Chest. 2021;160(3):994–1005.
Noth I, Cottin V, Chaudhuri N, Corte TJ, Johannson KA, Wijsenbeek M, et al. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021. https://doi.org/10.1183/13993003.01518-2020.
Barth S, Edwards C, Saini G, Haider Y, Williams NP, Storrar W, et al. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study. Respir Res. 2024;25(1):162.
Velauthapillai A, Moor CC, de Vries-Bouwstra JK, Wijsenbeek-Lourens MS, van den Ende CHM, Vonk MC. Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study. Lancet Rheumatol. 2025;7(3):e178–86.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–55.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35–45.
Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955–64.
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–12.
Alarcón-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. Amsterdam: Elsevier; 1987.
Papiris SA, Daniil ZD, Malagari K, Kapotsis GE, Sotiropoulou C, Milic-Emili J, et al. The medical research council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med. 2005;99(6):755–61.
Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339–43.
Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King’s brief interstitial lung disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804–10.
Tsai APY, Hur SA, Wong A, Safavi M, Assayag D, Johannson KA, et al. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease. Thorax. 2021;76(1):37–43.
Ryerson CJ, Vittinghoff E, Ley B, Lee JS, Mooney JJ, Jones KD, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest. 2014;145(4):723–8.
Nakshbandi G, Moor C., Aerts J., Wijsenbeek M. eHealth in pulmonary fibrosis: An international survey among healthcare providers and patients. European Respiratory Journal. 2020;56.
De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323.
Breekveldt-Postma NS, Koerselman J, Erkens JA, van der Molen T, Lammers JW, Herings RM, et al. Treatment with inhaled corticosteroids in asthma is too often discontinued. Pharmacoepidemiol Drug Saf. 2008;17(4):411–22.
Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13.
Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000;117(2):542–50.
Veit T, Barnikel M, Crispin A, Kneidinger N, Ceelen F, Arnold P, et al. Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study. Respir Res. 2020;21(1):270.
Anand R, McLeese R, Busby J, Stewart J, Clarke M, Man WD, et al. Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis. Eur Respir Rev. 2023. https://doi.org/10.1183/16000617.0248-2022.
Edwards C, Costello E, Cassidy N, Vick B, Russell AM. Use of the patientmpower app with home-based spirometry to monitor the symptoms and impact of fibrotic lung conditions: longitudinal observational study. JMIR Mhealth Uhealth. 2020;8(11):e16158.
Moor CC, van Leuven SI, Wijsenbeek MS, Vonk MC. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study. Rheumatology (Oxford). 2021;60(5):2467–71.
Barth S, Edwards C, Saini G, Haider Y, Williams NP, Storrar W, et al. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study. Respiratory Research. 2024;25(162).
Johannson KA, Vittinghoff E, Morisset J, Lee JS, Balmes JR, Collard HR. Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis. Eur Respir J. 2017. https://doi.org/10.1183/13993003.02406-2016.
Nakshbandi G, Moor CC, Magri T, Veltkamp M, Nijman SFM, Overbeek MJ, et al. Online home spirometry in national pulmonary fibrosis care: insights from daily practice. ERJ Open Res. 2025(In press).
Velauthapillai A, Schepers GMM, Vonk MC, van den Ende CHM. Experiences of systemic sclerosis patients with home monitoring of their pulmonary function: a qualitative study. Rheumatol Adv Pract. 2024;8(2):rkae036.
Akdogan A, Kilic L, Dogan I, Karadag O, Bilgen SA, Kiraz S, et al. Effect of capillaroscopic patterns on the pulse oximetry measurements in systemic sclerosis patients. Microvasc Res. 2015;98:183–6.
Garg R, Verma S. Pulse oximetry in scleroderma patients: concerns. Acta Anaesthesiol Scand. 2008;52(9):1303–4.
Beldner S, Rabinovich R, Polatsch DB. Scleroderma of the hand: evaluation and treatment. J Am Acad Orthop Surg. 2020;28(16):686–95.
Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, et al. The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford). 2000;39(2):122–32.
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–108.
Nakshbandi G, Moor CC, Wijsenbeek MS. Home monitoring for patients with ILD and the COVID-19 pandemic. Lancet Respir Med. 2020;8(12):1172–4.